Evaluation of GCF MMP-1, -8 and Growth Factor Levels in Smokers With Periodontal Health

NCT ID: NCT02014857

Last Updated: 2013-12-18

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 32 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2012-05-31
• Study Completion Date: 2013-09-30

Brief Summary

Increased levels of cytokines in GCF have been demonstrated in smoker subjects with chronic periodontitis. It is not surprising that increased levels of inflammation associated molecules in GCF has been observed in smokers with periodontitis. However, it is not clear if smoking has an influence on these parameters in periodontally healthy individuals. In the present study, it has been hypothesized that smoking might affect the levels of GCF MMPs and growth factors in young adults with periodontal health.

Detailed Description

The main objective of the present study was to investigate the GCF levels of MMP-1, MMP-8, TGF-β1, PDGF-AB and VEGF in smoker versus non-smoker periodontally healthy young adults.

A total of 32 periodontally healthy young adults including 16 smokers and 16 non-smokers, were recruited for the present cross-sectional study ( 18 female and 14 males; age range: 19 to 27 years).

All participants had a thorough full-mouth clinical examination. The measurement of probing depth (PD) and clinical attachment level (CAL) were assessed at six sites per tooth in the whole mouth, excluding third molars in all study participants. Bleeding on probing (BOP) and the amount of plaque accumulation were also evaluated.

GCF sampling sites were selected from the sites without BOP and plaque accumulation. GCF samples were obtained from buccal aspects of proximal sites in a single-rooted teeth in each individual participating in the present study. Paper strips† were carefully inserted 1 mm into the crevice for 30 seconds. Care was taken to avoid mechanical trauma. The absorbed GCF volume was estimated by a calibrated instrument. Then each strip from each patient were placed into one polypropylene tube before freezing at -40°C. The readings were converted to an actual volume (µl) reference to the standard curve. All GCF samples were stored at -40°C until the laboratory analyses.

Considering a difference of 50% in mean GCF levels of the biochemical markers and assuming standard deviations to be maximum 80% of the mean values and accepting a power of 90%, P value of 5% in smoker and non-smoker groups, minimum sample size was calculated.

Chi-square test was used to determine for differences in gender and smoking state between the study groups. Student t test was applied for comparison of age between smokers and non-smokers. Normality test was performed to evaluate the distribution of clinical periodontal parameters and levels of growth factor and MMP-1, -8. Growth factor and MMP levels were compared by Mann-Whitney U test in study groups.

Conditions

Smoking, Healthy Volenteers

Keywords

Smoking, gingival crevicular fluid, matrix metalloproteinases, intercellular signaling peptides and proteins, healthy volunteers

Study Design

• Observational Model Type: CASE_CONTROL
• Study Time Perspective: PROSPECTIVE

Study Groups

Periodonatlly healthy smokers

Gingival crevicular fluid sampling

Gingival Crevicular Fluid Sampling

Intervention Type: PROCEDURE

Periodontally healhty non-smokers

Gingival crevicular fluid sampling

Gingival Crevicular Fluid Sampling

Intervention Type: PROCEDURE

Interventions

Gingival Crevicular Fluid Sampling

Intervention Type: PROCEDURE

Eligibility Criteria

Inclusion Criteria

• Periodontally and systemically healthy individuals
• Have at least 20 teeth
• >10 cigarettes/day consumption for smoker group
• Non-smokers subjects were selected from periodontally healthy participants who had never smoked.

Exclusion Criteria

• Any health condition affecting their systemic status such as diabetes mellitus, immunologic disorders, human immunodeficiency virus infections, hepatitis were excluded
• Also pregnant and lactating women and those taking oral contraceptive drugs were not included in the study.
• Any antibiotic intake within the last 3 months and any periodontal treatment within 6 months

• Minimum Eligible Age: 19 Years
• Maximum Eligible Age: 27 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Ege University

OTHER

Sponsor Role: lead

Responsible Party

Gülnihal Eren, Research Asisstant

Research Assistant

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Gul Atilla, Professor

Role: STUDY_DIRECTOR

Ege University School of Dentistry

Hatice Oya Turkoglu, Assoc. Professor

Role: STUDY_CHAIR

Ege University School of Dentistry

Harika Atmaca, PhD

Role: STUDY_CHAIR

Celal Bayar University

Locations

Ege University School of Dentistry Department of Periodontology

Izmir, , Turkey (Türkiye)

Countries

Turkey (Türkiye)

Other Identifiers

Ege University

Identifier Type: -

Identifier Source: org_study_id